Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:09:50 EDT Thu 09 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:NGNE
- NEUROGENE INC -
Website unknown - click to update
15:09:50 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
NGNE
- Q
0.9
33.07
·
33.32
4.0
33.22
+0.32
1.0
16.1
509
521
33.86
33.87
32.935
53.00 12.49
14:52:35
May 07
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 521
More trades...
Time ET
Ex
Price
Change
Volume
14:52:35
Q
33.30
0.40
2
14:50:54
Q
33.29
0.39
5
14:50:54
Q
33.28
0.38
1
14:50:54
Q
33.25
0.35
54
14:50:54
Q
33.24
0.34
54
14:50:54
Q
33.23
0.33
37
14:50:54
Q
33.23
0.33
86
14:50:54
Q
33.23
0.33
14
14:50:54
Q
33.23
0.33
98
14:50:54
Q
33.22
0.32
100
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-07 06:19
U:NGNE
News Release
200
Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting
2024-04-26 16:14
U:NGNE
SEDAR Annual Report
803
SEDAR Annual Report
2024-04-22 16:36
U:NGNE
News Release
200
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
2024-03-28 18:28
U:NGNE
SEDAR Annual Report
803
SEDAR Annual Report
2024-03-28 18:15
U:NGNE
SEDAR MD & A
815
SEDAR MD & A
2024-03-28 18:09
U:NGNE
SEDAR Audited Annual Financial Statements
804
SEDAR Audited Annual Financial Statements
2024-03-18 16:14
U:NGNE
News Release
200
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
2024-03-04 07:30
U:NGNE
News Release
200
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial
2024-02-29 07:30
U:NGNE
News Release
200
Neurogene to Participate in Upcoming Investor Conferences
2024-01-16 07:00
U:NGNE
News Release
200
Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
2024-01-05 07:00
U:NGNE
News Release
200
Neurogene Announces Business Update and 2024 Outlook
2023-12-19 07:00
U:NGNE
News Release
200
Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
2023-12-14 19:00
U:NLTX
News Release
200
Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
2023-11-14 17:42
U:NLTX
SEDAR Interim MD & A
813
SEDAR Interim MD & A
2023-11-14 17:41
U:NLTX
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2023-09-22 08:00
U:NLTX
News Release
200
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
2023-08-11 18:55
U:NLTX
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2023-07-18 06:30
U:NLTX
News Release
200
Neurogene and Neoleukin Announce Definitive Merger Agreement